A deep data set from over a hundred clinical databases, manually curated by experts to ensure relevance and accuracy.

A best-in-class pipeline asset risk assessment for analytics and insights, portfolio strategy, business development and R&D teams that minimizes risk in drug development, streamlines productivity and lowers clinical development costs.

The platform uses forward-looking, machine learning-enabled probability of technical and regulatory success (PTRS) assessments to provide valuable insights.

Intelligencia.ai’s algorithms have demonstrated elevated levels of accuracy in predicting success and are continually refined with additional data.